Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | UNG | P13051 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.46 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.46 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.46 |
| ▸ | APP | P05067 | 6/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HNF4A | P41235 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30014296 | 0.83 | ALDH1A1 (0.48) | ALDH1A1UNGPTPN1PTPN2PTPN6 | |
| SCHEMBL436346 | 0.83 | ALDH1A1 (0.48) | ALDH1A1UNGPTPN1PTPN2PTPN6 | |
| SCHEMBL30589393 | 0.83 | ALDH1A1 (0.52) | ALDH1A1UNGPTPN1PTPN2PTPN6 | |
| SCHEMBL4613992 | 0.83 | ALDH1A1 (0.52) | ALDH1A1UNGPTPN1PTPN2PTPN6 | |
| SCHEMBL28926892 | 0.79 | ERN1 (0.53) | PTPN1KDM4EHNF4ALCKTRIM24 | |
| SCHEMBL130917 | 0.79 | PTPN1 (0.71) | ALDH1A1PTPN1PTPN2PTPN6APP | |
| SCHEMBL29354644 | 0.79 | PTPN1 (0.71) | ALDH1A1PTPN1PTPN2PTPN6APP | |
| SCHEMBL15169263 | 0.79 | CA12 (0.57) | ALDH1A1PTPN1PTGS2LCKTRIM24 | |
| SCHEMBL3040058 | 0.79 | ERN1 (0.49) | ALDH1A1UNGPTPN1PTGS2RAB9A | |
| SCHEMBL23677729 | 0.78 | POLB (0.52) | ALDH1A1UNGKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346752-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION | 2023-11-02 | — | — | US | disclosed |
| US-20230293497-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2023-09-21 | — | — | US | disclosed |
| US-11717514-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2023-08-08 | — | — | US | disclosed |
| EP-3915970-A1 | AROMATIC COMPOUNDS FROM FURANICS | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO (NL) | 2021-12-01 | — | — | EP | disclosed |
| EP-3419957-B1 | AROMATIC COMPOUNDS FROM FURANICS | TNO (NL) | 2021-09-29 | — | — | EP | disclosed |
| US-10562875-B2 | Aromatic compounds from furanics | NEDERLANDSE ORGANISAITE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2020-02-18 | — | — | US | disclosed |
| US-20190023678-A1 | AROMATIC COMPOUNDS FROM FURANICS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2019-01-24 | — | — | US | disclosed |
| CN-104281006-B | Radiation-ray sensitive composition | 三菱瓦斯化学株式会社 | 2019-01-22 | — | — | CN | disclosed |
| CN-108008600-A | Radiation-ray sensitive composition | 三菱瓦斯化学株式会社 | 2018-05-08 | — | — | CN | disclosed |
| US-9951324-B2 | PSMA binding ligand-linker conjugates and methods for using | PURDUE RESEARCH FOUNDATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-20130116195-A1 | Binding ligand linked drug delivery conjugates of tubulysins | LEAMON CHRISTOPHER PAUL (US) | 2013-05-09 | — | — | US | disclosed |
| US-20120322741-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2012-12-20 | — | — | US | disclosed |
| US-20120270791-A1 | Methods and Compositions for Treating and Diagnosing Kidney Disease | LEAMON CHRISTOPHER PAUL (US) | 2012-10-25 | — | — | US | disclosed |
| US-20120065149-A1 | Vitamin receptor binding drug delivery conjugates | VLAHOV IONTCHO R (US) | 2012-03-15 | — | — | US | disclosed |
| US-20120022245-A1 | FOLATE TARGETING OF NUCLEOTIDES | PURDUE RESEARCH FOUNDATION (US) | 2012-01-26 | — | — | US | disclosed |
| US-20110288152-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2011-11-24 | — | — | US | disclosed |
| US-20100324008-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | PURDUE RESEARCH FOUNDATION (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100323973-A1 | CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS | ENDOCTYE, INC. | 2010-12-23 | — | — | US | disclosed |
| EP-2259133-A1 | COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE | Sharp Kabushiki Kaisha (JP) | 2010-12-08 | — | — | EP | disclosed |
| CN-101528653-A | Radiation-sensitive composition | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-09-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293497-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | ALDH1A1 2843/4885UNG 2767/4885PTPN1 4026/4885 |
| US-20120022245-A1 | FOLATE TARGETING OF NUCLEOTIDES | FOLR1, FOLR2, DHFR | ALDH1A1 1932/4885UNG 142/4885PTPN1 3025/4885 |
| US-20130116195-A1 | Binding ligand linked drug delivery conjugates of tubulysins | TEK, TEKT1, CD2BP2 | ALDH1A1 4745/4885UNG 3392/4885PTPN1 2116/4885 |
| US-20110288152-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | ALDH1A1 2290/4885UNG 1756/4885PTPN1 3809/4885 |
| US-20190023678-A1 | AROMATIC COMPOUNDS FROM FURANICS | PAH, AOX1, TYR | ALDH1A1 180/4885UNG 810/4885PTPN1 2246/4885 |
| US-20120065149-A1 | Vitamin receptor binding drug delivery conjugates | VDR, CYP2R1, CYP24A1 | ALDH1A1 931/4885UNG 2969/4885PTPN1 3504/4885 |
| US-20120270791-A1 | Methods and Compositions for Treating and Diagnosing Kidney Disease | VDR, GC, CYP24A1 | ALDH1A1 2229/4885UNG 3469/4885PTPN1 2537/4885 |
| US-20120322741-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | ALDH1A1 2748/4885UNG 2770/4885PTPN1 4096/4885 |
| US-10562875-B2 | Aromatic compounds from furanics | PAH, AOX1, TYR | ALDH1A1 180/4885UNG 810/4885PTPN1 2246/4885 |
| US-20100324008-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | ALDH1A1 2843/4885UNG 2767/4885PTPN1 4026/4885 |
| US-11717514-B2 | PSMA binding ligand-linker conjugates and methods for using | FOLH1, KLK3, PSMA1 | ALDH1A1 2843/4885UNG 2767/4885PTPN1 4026/4885 |
| US-20100323973-A1 | CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS | CD44, HAVCR2, HCAR1 | ALDH1A1 2723/4885UNG 3216/4885PTPN1 3635/4885 |
| US-20230346752-A1 | PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING | FOLH1, KLK3, PSMA1 | ALDH1A1 2843/4885UNG 2767/4885PTPN1 4026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.